These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37355583)

  • 21. Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
    Malahleha M; Laher F; Dilraj A; Smith P; Gray GE; Grove D; Odhiambo JA; Andrasik MP; Grunenberg NA; Moodie Z; Huang Y; Borate BR; Gillespie KM; Allen M; Atujuna M; Singh N; Kalonji D; Meintjes G; Kotze P; Bekker LG; Janes H
    AIDS Behav; 2023 Sep; 27(9):3027-3037. PubMed ID: 36929319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial.
    Yapa HM; De Neve JW; Chetty T; Herbst C; Post FA; Jiamsakul A; Geldsetzer P; Harling G; Dhlomo-Mphatswe W; Moshabela M; Matthews P; Ogbuoji O; Tanser F; Gareta D; Herbst K; Pillay D; Wyke S; Bärnighausen T
    PLoS Med; 2020 Oct; 17(10):e1003150. PubMed ID: 33027246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Bekker LG; Garrett N; Goga A; Fairall L; Reddy T; Yende-Zuma N; Kassanjee R; Collie S; Sanne I; Boulle A; Seocharan I; Engelbrecht I; Davies MA; Champion J; Chen T; Bennett S; Mametja S; Semenya M; Moultrie H; de Oliveira T; Lessells RJ; Cohen C; Jassat W; Groome M; Von Gottberg A; Le Roux E; Khuto K; Barouch D; Mahomed H; Wolmarans M; Rousseau P; Bradshaw D; Mulder M; Opie J; Louw V; Jacobson B; Rowji P; Peter JG; Takalani A; Odhiambo J; Mayat F; Takuva S; Corey L; Gray GE; ;
    Lancet; 2022 Mar; 399(10330):1141-1153. PubMed ID: 35305740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    Laher F; Moodie Z; Cohen KW; Grunenberg N; Bekker LG; Allen M; Frahm N; Yates NL; Morris L; Malahleha M; Mngadi K; Daniels B; Innes C; Saunders K; Grant S; Yu C; Gilbert PB; Phogat S; DiazGranados CA; Koutsoukos M; Van Der Meeren O; Bentley C; Mkhize NN; Pensiero MN; Mehra VL; Kublin JG; Corey L; Montefiori DC; Gray GE; McElrath MJ; Tomaras GD
    PLoS Med; 2020 Feb; 17(2):e1003038. PubMed ID: 32092060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collaborative care for the detection and management of depression among adults receiving antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial.
    Fairall L; Petersen I; Zani B; Folb N; Georgeu-Pepper D; Selohilwe O; Petrus R; Mntambo N; Bhana A; Lombard C; Bachmann M; Lund C; Hanass-Hancock J; Chisholm D; McCrone P; Carmona S; Gaziano T; Levitt N; Kathree T; Thornicroft G;
    Trials; 2018 Mar; 19(1):193. PubMed ID: 29566739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
    Adis International Ltd
    Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women.
    Latka MH; Fielding K; Gray GE; Bekker LG; Nchabeleng M; Mlisana K; Nielson T; Roux S; Mkhize B; Mathebula M; Naicker N; de Bruyn G; Kublin J; Churchyard GJ;
    PLoS One; 2012; 7(4):e31387. PubMed ID: 22532824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
    Moodie Z; Metch B; Bekker LG; Churchyard G; Nchabeleng M; Mlisana K; Laher F; Roux S; Mngadi K; Innes C; Mathebula M; Allen M; Bentley C; Gilbert PB; Robertson M; Kublin J; Corey L; Gray GE
    PLoS One; 2015; 10(9):e0137666. PubMed ID: 26368824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms.
    de Lusignan S; Jones N; Dorward J; Byford R; Liyanage H; Briggs J; Ferreira F; Akinyemi O; Amirthalingam G; Bates C; Lopez Bernal J; Dabrera G; Eavis A; Elliot AJ; Feher M; Krajenbrink E; Hoang U; Howsam G; Leach J; Okusi C; Nicholson B; Nieri P; Sherlock J; Smith G; Thomas M; Thomas N; Tripathy M; Victor W; Williams J; Wood I; Zambon M; Parry J; O'Hanlon S; Joy M; Butler C; Marshall M; Hobbs FDR
    JMIR Public Health Surveill; 2020 Jul; 6(3):e19773. PubMed ID: 32484782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical Guidelines for Standardised Resolution of Important Protocol Deviations in Clinical Trials Conducted in Sub-Saharan Africa.
    Zemsi A; Nekame LJG; Mohammed N; Batchilly ES; Dabira E; Sillah SO; Sey G; Williams DH; Dondeh BL; Cerami C; Clarke E; D'Alessandro U
    Ther Innov Regul Sci; 2024 May; 58(3):395-403. PubMed ID: 38285370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.
    Dorward J; Khubone T; Gate K; Ngobese H; Sookrajh Y; Mkhize S; Jeewa A; Bottomley C; Lewis L; Baisley K; Butler CC; Gxagxisa N; Garrett N
    Lancet HIV; 2021 Mar; 8(3):e158-e165. PubMed ID: 33549166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinako, a study on HIV competent households in South Africa: a cluster-randomised controlled trial protocol.
    Masquillier C; Knight L; Campbell L; Sematlane N; Delport A; Dube T; Wouters E
    Trials; 2020 Feb; 21(1):154. PubMed ID: 32041656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa.
    Mabuka T; Ncube N; Ross M; Silaji A; Macharia W; Ndemera T; Lemeke T
    BMC Public Health; 2023 Aug; 23(1):1492. PubMed ID: 37542267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.